D. Wilkinson

Mechanisms contributing to ozone-induced bronchial hyperreactivity in guinea-pigs.

M. Yeadon, V. Darley-Usmar, V. O'Leary, 1992, Pulmonary pharmacology.

The disposition and metabolic fate of 14C-meropenem in man.

S. Moss, S. Haworth, A. Featherstone, 1993, Xenobiotica; the fate of foreign compounds in biological systems.

The utility of liver function tests and abdominal ultrasound in infectious mononucleosis—A systematic review

O. Edafe, D. Wilkinson, E. Tan, 2022, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

The pharmacokinetics of meropenem in volunteers.

R. Bax, M. Hutchison, S. Haworth, 1989, The Journal of antimicrobial chemotherapy.

Canrenone--the principal active metabolite of spironolactone?

L. Ramsay, M. Tidd, J. Shelton, 1976, British journal of clinical pharmacology.

Comparative Pharmacokinetics of Two Fast-Dissolving Oral Ibuprofen Formulations and a Regular-Release Ibuprofen Tablet in Healthy Volunteers

M. Pellett, T. Schettler, D. Wilkinson, 2001 .

The effects of a 5-HT2 receptor antagonist (ICI 169,369) on changes in waking EEG, pupillary responses and state of arousal in human volunteers.

D. Millson, S. Haworth, A. Rushton, 1991, British journal of clinical pharmacology.